Bristol Myers Squibb has pioneered the development of immuno-oncology therapies and continues to diversify in drug development for the treatment of cancers. Our world-class Translational Development organization is exploring new aspects of tumor and immune biology to create tailored, individualized treatment strategies that will offer the greatest possible benefit to patients. We are looking for experienced translational scientists to help drive improved understanding of disease biology, mechanism of action, and predictive biomarkers in our late-stage clinical oncology portfolio. Ideal candidates will possess a strong scientific background, effective communication skills, and experience working in a matrixed industrial environment. The Asset Lead role will be responsible for development and execution of translational strategies in solid tumor oncology for assigned programs. Key responsibilities of this role are to act as a lead scientist to implement and generate and deliver on innovative biomarker strategies for clinical programs including patient selection, differentiation, resistance, combinations and indication selection. The Asset Lead will develop reports and publications on translational data generated to support asset development and contribute to regulatory submissions. This individual will work on cross-functional project teams to drive execution of translational/biomarker plans working with disease and lab scientists, as well as BMS members from clinical, medical, commercial, regulatory, and diagnostics. Individual will also engage with external academic collaborators/Key Opinion Leaders (KOLs).
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree